Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

72.10 +0.20 (+0.28%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Stay informed with the top movers within the S&P500 index on Tuesday. ↗

May 19, 2026

Via Chartmill

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

May 18, 2026

From DexCom, Inc.

Via Business Wire

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day ↗

May 16, 2026

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose monitoring, international expansion and...

Via MarketBeat

What's going on in today's session: S&P500 movers ↗

May 15, 2026

Via Chartmill

These S&P500 stocks have an unusual volume in today's session ↗

May 01, 2026

Via Chartmill

DexCom Inc (NASDAQ:DXCM): A GARP Stock with Affordable Growth and Strong Fundamentals ↗

May 01, 2026

Via Chartmill

DexCom (NASDAQ:DXCM) Beats Q1 Earnings Forecasts, But Guidance and Revenue Miss Fuel After-Hours Drop ↗

April 30, 2026

Via Chartmill

DEXCOM INC (NASDAQ:DXCM) Shows Strong Fundamentals and a Promising Technical Breakout Setup ↗

April 24, 2026

Via Chartmill

Uncover the latest developments among S&P500 stocks in today's session. ↗

May 15, 2026

Via Chartmill

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

May 14, 2026

From DexCom, Inc.

Via Business Wire

Sell in May and Go Away—Starting With These 3 Stocks ↗

May 12, 2026

Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call.

Via MarketBeat

Topics Artificial Intelligence

2 Mid-Cap Stocks with Impressive Fundamentals and 1 We Question

May 12, 2026

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...

Via StockStory

3 Quality Compounders Worth Your Attention

May 08, 2026

Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr...

Via StockStory

5 Insightful Analyst Questions From DexCom’s Q1 Earnings Call

May 07, 2026

DexCom’s first quarter saw revenue growth driven by new product launches and increased adoption, particularly among people with type 2 diabetes who are not o...

Via StockStory

Topics Earnings Economy

3 Reasons Analysts Love DexCom ↗

May 05, 2026

Via MarketBeat

Dexcom to Host Investor Day on May 14, 2026

May 05, 2026

From DexCom, Inc.

Via Business Wire

Friday's session: gap up and gap down stock in the S&P500 index ↗

May 01, 2026

Via Chartmill

What's going on in today's pre-market session: S&P500 movers ↗

May 01, 2026

Via Chartmill

DXCM Q1 Deep Dive: U.S. Growth Moderates as Product Momentum and Coverage Expansion Drive Strategy

May 01, 2026

Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 15% year on year to $1.19 bil...

Via StockStory

2 Nasdaq 100 Stocks with Solid Fundamentals and 1 We Find Risky

May 01, 2026

The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a win...

Via StockStory

DexCom (DXCM) Q1 2026 Earnings Transcript ↗

April 30, 2026

DexCom (DXCM) Q1 2026 Earnings Transcript

Via The Motley Fool

Top S&P500 movers in Thursday's after hours session ↗

April 30, 2026

Via Chartmill

DexCom (NASDAQ:DXCM) Exceeds Q1 CY2026 Expectations But Stock Drops

April 30, 2026

Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 15% year on year to $1.19 b...

Via StockStory

Dexcom Reports First Quarter 2026 Financial Results

April 30, 2026

From DexCom, Inc.

Via Business Wire

2026 Market Cap Madness Championship: Loren v. Emily ↗

April 29, 2026

It’s time to crown a winner: defending champion Emily Flippen faces off against Cinderella challenger Loren Horst in the Market Cap Madness World Championship.

Via The Motley Fool

DexCom (DXCM) Q1 Earnings: What To Expect

April 28, 2026

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings this Thursday after market close. Here’s what investors should know. DexCom beat analy...

Via StockStory

Topics Artificial Intelligence

1 Cash-Producing Stock to Target This Week and 2 Facing Challenges

April 24, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins ↗

April 23, 2026

Drugmakers won't be the only ones cashing in on the rising popularity of weight loss medicines.

Via The Motley Fool

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom ↗

April 20, 2026

They offer investors very different value propositions.

Via The Motley Fool

2 Healthcare Stocks That Could Outperform the Market Over the Next Decade ↗

April 16, 2026

Both have helped transform their respective industries.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.